amitriptyline has been researched along with Chronic Lung Injury in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Zhu, Y | 1 |
| Wu, Y | 1 |
| Yan, QG | 1 |
| Peng, XY | 1 |
| Xiang, XM | 1 |
| Xue, MY | 1 |
| Li, QH | 1 |
| Liu, LM | 1 |
| Li, T | 1 |
1 other study available for amitriptyline and Chronic Lung Injury
| Article | Year |
|---|---|
Synergistic effects of EMPs and PMPs on pulmonary vascular leakage and lung injury after ischemia/reperfusion.
Topics: Amitriptyline; Animals; Blood Platelets; Capillary Permeability; Caveolin 1; Cell-Derived Microparti | 2020 |